Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the EndotheliumReport as inadecuate

Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium - Download this document for free, or read online. Document in PDF available to download.

Vitamin D is a known modulator of inflammation. Native dietary vitamin D3 is thought to be bio-inactive, and beneficial vitamin D3 effects are thought to be largely mediated by the metabolite 1,25OH2D3. Reduced serum levels of the most commonly measured precursor metabolite, 25OHD3, is linked to an increased risk of multiple inflammatory diseases, including: cardiovascular disease, arthritis, multiple sclerosis, and sepsis. Common to all of these diseases is the disruption of endothelial stability and an enhancement of vascular leak. We previously performed an unbiased chemical suppressor screen on a genetic model of vascular instability, and identified cholecalciferol D3, dietary Vitamin D3 as a factor that had profound and immediate stabilizing and therapeutic effects in that model. In this manuscript we show that the presumed inactive sterol, D3, is actually a potent and general mediator of endothelial stability at physiologically relevant concentrations. We further demonstrate that this phenomenon is apparent in vitamin D3 metabolites 25OHD3 and 1,25OH2D3, and that the effects are independent of the canonical transcription-mediated vitamin D pathway. Our data suggests the presence of an alternative signaling modality by which D3 acts directly on endothelial cells to prevent vascular leak. The finding that D3 and its metabolites modulate endothelial stability may help explain the clinical correlations between low serum vitamin D levels and the many human diseases with well-described vascular dysfunction phenotypes.

Author: Christopher C. Gibson , Chadwick T. Davis , Weiquan Zhu, Jay A. Bowman-Kirigin, Ashley E. Walker, Zhengfu Tai, Kirk R. Thomas, An



Related documents